Revenue
attach_money0M USD
YoY +149.2%
GDTCCytoMed Therapeutics Limited$ --
CytoMed Therapeutics Limited
GDTC
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-2M USD
YoY -48.9%
Net Income
verified-1M USD
YoY -25.0%
EPS
paid-0.11$
YoY -17.9%
Revenue
$130,625
BEAT
$130,000
$100,043
$130,000
$105,705
$130,625
$260,000
$336,373
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
+78,210 $+149.2%
Net Income
$-1.3M
MISS
$-472,370
$-835,042
$-472,370
$-882,300
$-1.3M
$-944,740
$-3.1M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
-269,163 $-25.0%
Surprise History
ActualEstimate
FY2025MISS
Future Forecast
No forecast data
